En
Da
Fr
De
Sv
Deal History
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Insights
News
Newsletter
Research
About us
Company
Team
Offices
Globalscope
Career
Events
Contact
En
Da
Fr
De
Sv
Main menu button
Team
Deals
Contact
Equity Research
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Svenska Aerogel
Thinc Jetty
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Corporate Finance
Equity Research
Events
In Media
M&A Know-how
Macro and markets
Market Snapshots
Uncategorized
01 Jun 2022
Research Update Nischer Properties, Q1 2022: Higher costs and rising property values
Equity Research
Nischer Properties
30 May 2022
First Impression Nischer Properties, Q1 2022: Good increases in property values
Equity Research
Nischer Properties
09 Mar 2022
Research Update Nischer Properties, Q4 2021: Less increase in value but financially strong
Equity Research
Nischer Properties
28 Feb 2022
First Impression, Nischer Properties Q4 2021: Impairment of property value dragged down results
Equity Research
Nischer Properties
09 Dec 2021
Research Update, Q3 2021 Nischer Properties: Rights issue provides financial strength
Equity Research
Nischer Properties
29 Nov 2021
First impression Nischer Properties, Q3 2021: Construction output as expected- result slightly lower
Equity Research
Nischer Properties